Survey shows mixed views from patients on smart pills
March 12, 2019 / Richard Staines
A new study from Ernst and Young has shown that consumers are driving demand for use of digital health technology – but some are unconvinced about pharma innovations such as smart pills. The EY Future of Health in England report also shows that consumers are edging towards impatience with physicians who still favor traditional face-to-face consultations with patients. The survey of both potential patients and physicians showed that 59% of consumers are interested in having a virtual consultation, but only 7% have actually experienced one. Other key trends in health technology include the fact that companies outside the sector will become increasingly involved in the healthcare industry. There was a mixed verdict on pharma innovations in high tech pharma products such as smart pills, that travel in the blood and transmit messages to a phone.